Description
Learning Objectives
Upon completion of this activity, the learner will be able to:
- Describe the incidence, symptomatology, and risk factors for ifosfamide-induced neurotoxicity (IIN)
- Review the pathophysiology, differential diagnosis, evaluation, and typical management of IIN
- Explore ways nurses and advanced practice nurses might provide education as they care for children who develop IIN
Individual Learning Needs Assessment (ILNA) Coding
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. You may claim 1 CNE in one of the following ILNA categories: Treatment Modalities and Side Effects, OR Symptom Management, OR Care of the Pediatric Hem/Onc Patient.
Please reach out to the Education Team at education@aphon.org with your name, the email associated with your APHON account, and the above ILNA category you would like to have reflected on your certificate and APHON can update your completion certificate to reflect your choice.
JOPHON NCPD (2024 March-April) - Genomes for Nurses: Understanding and Overcoming Barriers to Nurses Utilizing Genomics
JOPHON CNE (May/June 2023): Pediatric Chemotherapy Infusions in Outpatient Examination Rooms: A Novel Patient Care Approach
JOPHON CNE (Nov/Dec 2022): Ifosfamide-Induced Neurotoxicity in Children with Solid Tumors: A Seven Year Retrospective Analysis of Incidence and Risk Factors
JOPHON CNE (Mar/Apr 2022): Nursing Presence in Pediatric Oncology: A Scoping Review
Foundations of Pediatric Hematopoietic Stem Cell Transplantation: 3rd edition. (2022)



